Clinical Trials
5
Active:0
Completed:3
Trial Phases
1 Phases
Phase 2:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 2
5 (100.0%)A Single-Center, Double-Blind (DB) Study of MEM 3454 on P50 Sensory Gating and Mismatch Negativity in Schizophrenia Patients
- First Posted Date
- 2008-07-31
- Last Posted Date
- 2008-07-31
- Lead Sponsor
- Memory Pharmaceuticals
- Target Recruit Count
- 12
- Registration Number
- NCT00725855
- Locations
- 🇺🇸
University of Colorado Health Sciences Center, Denver, Colorado, United States
Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With Schizophrenia
Phase 2
- Conditions
- Cognitive Impairment Associated With Schizophrenia
- Interventions
- Drug: Placebo for MEM 3454
- First Posted Date
- 2008-01-30
- Last Posted Date
- 2008-12-08
- Lead Sponsor
- Memory Pharmaceuticals
- Target Recruit Count
- 160
- Registration Number
- NCT00604760
- Locations
- 🇺🇸
Telecare-Cresta Loma, Lemon Grove, California, United States
🇺🇸Newport Bay Hospital, Newport Beach, California, United States
🇺🇸Excell Research, Oceanside, California, United States
Safety and Efficacy of MEM 3454 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease
Phase 2
Completed
- Conditions
- Alzheimer's Disease
- First Posted Date
- 2007-04-02
- Last Posted Date
- 2008-05-06
- Lead Sponsor
- Memory Pharmaceuticals
- Target Recruit Count
- 80
- Registration Number
- NCT00454870
Safety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I Disorder
Phase 2
Completed
- Conditions
- Bipolar Disorder With Manic or Mixed Episodes
- First Posted Date
- 2006-09-12
- Last Posted Date
- 2008-05-06
- Lead Sponsor
- Memory Pharmaceuticals
- Target Recruit Count
- 60
- Registration Number
- NCT00374920
Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease
- First Posted Date
- 2005-11-23
- Last Posted Date
- 2008-05-06
- Lead Sponsor
- Memory Pharmaceuticals
- Target Recruit Count
- 183
- Registration Number
- NCT00257673
News
No news found